BlackRock Health Sciences Term Trust (NYSE:BMEZ) Sees Large Increase in Short Interest

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 124,200 shares, a growth of 926.4% from the November 30th total of 12,100 shares. Based on an average daily volume of 297,200 shares, the short-interest ratio is presently 0.4 days.

Insider Activity at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. bought 1,633 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was acquired at an average cost of $15.89 per share, with a total value of $25,948.37. Following the transaction, the insider now directly owns 20,653,378 shares in the company, valued at approximately $328,182,176.42. This trade represents a 0.01 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last ninety days, insiders have bought 54,721 shares of company stock worth $866,427.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Brown Brothers Harriman & Co. purchased a new stake in BlackRock Health Sciences Term Trust in the third quarter valued at approximately $32,000. K2 Principal Fund L.P. purchased a new position in BlackRock Health Sciences Term Trust during the third quarter valued at approximately $158,000. Shaker Financial Services LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the 2nd quarter worth approximately $184,000. Dakota Wealth Management increased its holdings in shares of BlackRock Health Sciences Term Trust by 23.4% during the 3rd quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares in the last quarter. Finally, Jane Street Group LLC purchased a new stake in BlackRock Health Sciences Term Trust during the third quarter worth $357,000.

BlackRock Health Sciences Term Trust Trading Down 0.5 %

NYSE:BMEZ traded down $0.08 during midday trading on Thursday, reaching $14.81. 480,831 shares of the stock traded hands, compared to its average volume of 283,198. The business has a 50-day moving average of $15.45 and a two-hundred day moving average of $15.60. BlackRock Health Sciences Term Trust has a 12-month low of $14.38 and a 12-month high of $16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which was paid on Monday, December 23rd. Investors of record on Monday, December 16th were given a $0.1781 dividend. This represents a $2.14 annualized dividend and a dividend yield of 14.43%. The ex-dividend date of this dividend was Monday, December 16th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.